Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Cardiovascular Endocrinology
|
October 25, 2019
Nonalcoholic fatty liver disease: implications for cardiovascular risk
Amreen Dinani, Arun Sanyal
Gastroenterology & Hepatology
|
May 26, 2021
Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease
James Philip Esteban, Amreen Dinani
Translational Gastroenterology and Hepatology
|
January 7, 2021
Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industry
Amon Asgharpour, Amreen Dinani, Scott L Friedman
Journal of Medical Microbiology
|
June 23, 2009
Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis
Amreen Dinani, Nessrine Ktaich, Carl Urban, et al.
Journal of Gastrointestinal Cancer
|
September 3, 2010
High rates of advanced gastric cancer in community of Flushing, New York
Amreen Dinani, Amit Desai, Nina Kohn, et al.
Gastro Hep Advances
|
August 12, 2024
Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Is Independently Associated With Reduced Renal Function
Carolina Villarroel, Gres Karim, Mantej Sehmbhi, et al.
European Journal of Gastroenterology & Hepatology
|
January 4, 2021
The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review
Yi Chia Wu, Philip M Chuang, Rachel Pinotti, et al.
The Journal of Emergency Medicine
|
November 20, 2020
Nontargeted Hepatitis C Screening in an Urban Emergency Department in New York City
Ethan A Cowan, Amreen Dinani, Samantha Brandspiegel, et al.
Contemporary Clinical Trials
|
November 23, 2021
Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C)
Andrew H Talal, Marianthi Markatou, Elisavet M Sofikitou, et al.
Gastro Hep Advances
|
July 11, 2026
Progression of Metabolic Dysfunction-Associated Steatohepatitis in US Adults Using Linked Records and Claims
Yestle Kim, Romina Fakhraei, John C O'Donnell, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Cardiovascular Endocrinology
|
October 25, 2019
Nonalcoholic fatty liver disease: implications for cardiovascular risk
Amreen Dinani, Arun Sanyal
Gastroenterology & Hepatology
|
May 26, 2021
Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease
James Philip Esteban, Amreen Dinani
Translational Gastroenterology and Hepatology
|
January 7, 2021
Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industry
Amon Asgharpour, Amreen Dinani, Scott L Friedman
Journal of Medical Microbiology
|
June 23, 2009
Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis
Amreen Dinani, Nessrine Ktaich, Carl Urban, et al.
Journal of Gastrointestinal Cancer
|
September 3, 2010
High rates of advanced gastric cancer in community of Flushing, New York
Amreen Dinani, Amit Desai, Nina Kohn, et al.
Gastro Hep Advances
|
August 12, 2024
Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Is Independently Associated With Reduced Renal Function
Carolina Villarroel, Gres Karim, Mantej Sehmbhi, et al.
European Journal of Gastroenterology & Hepatology
|
January 4, 2021
The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review
Yi Chia Wu, Philip M Chuang, Rachel Pinotti, et al.
The Journal of Emergency Medicine
|
November 20, 2020
Nontargeted Hepatitis C Screening in an Urban Emergency Department in New York City
Ethan A Cowan, Amreen Dinani, Samantha Brandspiegel, et al.
Contemporary Clinical Trials
|
November 23, 2021
Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C)
Andrew H Talal, Marianthi Markatou, Elisavet M Sofikitou, et al.
Gastro Hep Advances
|
July 11, 2026
Progression of Metabolic Dysfunction-Associated Steatohepatitis in US Adults Using Linked Records and Claims
Yestle Kim, Romina Fakhraei, John C O'Donnell, et al.
Page
of 2